Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Anti Viral Drugs Companies

Anti-viral drugs are designed to treat viral infections by inhibiting the replication of viruses.

Anti-viral drugs Key Companies


Latest Anti-viral drugs Companies Update

Pfizer's Paxlovid transition to commercial distribution: November 2023, Pfizer's oral COVID-19 treatment Paxlovid transitioned from government-managed distribution to traditional commercial channels. This move aims to improve patient access and availability beyond government supply.

Gilead Sciences receives FDA approval for Sunvepra for cytomegalovirus (CMV) infections: September 2023, Gilead Sciences received FDA approval for Sunvepra (ciluprevvir/ganciclovir) for the treatment of CMV infections in adult hematopoietic stem cell transplant recipients.

Roche secures positive Phase 3 trial results for Actemra/RoActemra combination in preventing CMV disease: October 2023, Roche announced positive results from a Phase 3 trial evaluating the combination of Actemra/RoActemra (tocilizumab) with standard-of-care anti-viral therapy for preventing CMV disease in adult kidney transplant recipients.

List of Anti-viral drugs Key Companies in the Market

  • Johnson & Johnson

  • Merck & Co. Inc.

  • Gilead Sciences Inc.

  • Hoffmann-La Roche Ltd.

  • GlaxoSmithKline Plc

  • Abbott Laboratories

  • Novartis International AG

  • Astra Zeneca AB

  • Cipla Inc.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.